Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

More documents

Recommendations

Info

Richtlijn: Erfelijke darmkanker (1.0)screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int JGynecol Cancer 2006;16 Suppl 1:54-9.115 - Galiatsatos PGaliatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385-98.116 - Gallagher MCGallagher MC, Shankar A, Groves CJ, Russel RC, Phillips RK. Pylorus-preservingpancreaticoduodenectomy for advanced duodenal disease in familial adenomatous duodenal polyposis. BrJ Surg 2004; 91:1157-64.117 - Gallagher MCGallagher MC, Phillips RKS, Bulow S. Surveillance and management of upper gastrointestinal disease inFamilial Adenomatous Polyposis. Fam Cancer 2006;5:263-73.118 - Geirdal AOGeirdal AO, Reichelt JG, Dahl AA, Heimdal K, Maehle L, Stormorken A et al. Psychological distress inwomen at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.Fam Cancer 2005;4;121-6.119 - McGettigan PMcGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of theobservational studies of selective and nonselective inhibitors of cyclooxygenase. JAMA 2006;296:1633-44.120 - Giardiello FMGiardiello FM, Brensingen JP, Petersen GM, Luce MC, Hylind LM, Bacon JA et al. The use andinterpretation of commercial APC genetic testing for familial adenomatous polyposis. N Engl J Med1997;336:823-7.121 - Giardiello FMGiardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer andgenetic testing. Gastroenterology 2001;121:198-213.122 - Giardiello FMGiardiello FM, Casero RA Jr, Hamilton SR, Hylind HMN, Trimbath JD, Geiman DE et al. Prostanoids,ornithine decarboxylase and polyamines in primary chemoprevention of familial adenomatous polyposis.Gastroenterology 2004;49:1259-61.123 - Gigerenzer GGigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 2003;327:741-4.124 - Gille JJPGille JJP, Hogervorst FBL, Pals G, Wijnen JT, Van Schooten RJ, Dommering CJ et al. Genomic deletionsof MSH2 and Mlh1 in colorectal cancer families detected by a novel mutation detection approach. Br JCancer 2002;87:892-7.125 - Gismondi VGismondi V, Meta M, Bonelli O, Radice P, Sala P, Bertario L et al. Prevalence of the Y165C, G382D, and1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli andcolorectal adenomas. Int J Cancer 2004;109:680-4.126 - Godard BGodard B, Hurlimann T, Letendre M, Egalite N, INHERIT BRCAs. Guidelines for disclosing geneticinformation to family members: from development to use. Fam Cancer 2006; 5: 103-16.03/11/08 Erfelijke darmkanker (1.0) 95
Richtlijn: Erfelijke darmkanker (1.0)127 - Graham DJGraham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G et al. Risk of acute myocardial infarctionand sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selectivenon-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005;365:475-81.128 - Grimes DAGrimes DA, Snively GR. Patients' understanding of medical riks: implication for genetic counselling.Obstet. Gynaecol. 1999;93:910-4.129 - Gritz ERGritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG et al. Psychological impact of genetictesting for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-10.130 - Grover SGrover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer historyand referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2004;2:813-9.131 - Groves CJGroves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familialadenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-41.132 - Guldenschuh IGuldenschuh I, Hurlimann R, Muller A, Ammann R, Mullhaupt B, Dobbie Z et al. Relationship betweenAPC genotype, polyp distribution and oral sulindac treatment in the colon and rectum of patients withfamilial adenomatous polyposis. Dis Colon Rectum 2001;44:1090-7.133 - Gurbuz AKGurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV et al. Desmoid tumours infamilial adenomatous polyposis. Gut 1994;35:377-81.134 - Haan M. deHaan M de, Lisdonk E van de, Voorn TH. De Kern van de Huisartsgeneeskunde. Bunge Utrecht 1992.135 - Habr-Gama AHabr-Gama A, Bringel RW, Nahas SC, Araujo SE, Souza Junior AH, Calache JE et al. Bowel preparationfor colonoscopy: comparison of mannitol and sodium phosphate. Results of a prospective randomizedstudy. Rev Hosp Clin Fac Med Sao Paulo 1999;54:187-92.136 - Hadley DWHadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ et al. Genetic counseling andtesting in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003;163:573-82.137 - Hadley DWHadley DW, Jenkins JF, Dimond E, De Carvalho M, Kirsch I, Palmer CG. Colon cancer screeningpractices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol2004;22;39-44.138 - Halbert CHHalbert CH, Lynch H, Lynch J, Main D, Kucharski S, Rustgi AK et al. Colon cancer screening practicesfollowing genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med2004;164:1881-7.03/11/08 Erfelijke darmkanker (1.0) 96
Page 1 and 2:
ERFELIJKE DARMKANKERLandelijke rich
Page 3 and 4:
InhoudsopgaveReferenties...........
Page 5 and 6:
Richtlijn: Erfelijke darmkanker (1.
Page 7 and 8:
Page 9 and 10:
Incidentie en risico'sLiteratuurbes
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
DiagnostiekLiteratuurbespreking:Dit
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Restrisico op mutatieRichtlijn: Erf
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48: Richtlijn: Erfelijke darmkanker (1.
Page 53: BehandelingLiteratuurbespreking:Dit
Page 71: Richtlijn: Erfelijke darmkanker (1.
Page 116 and 117: Gastroenterology 2004 Jul;127(1):9-
Page 118 and 119: Bijlagen1. Samenstelling werkgroepS
Page 142: Richtlijn: Erfelijke darmkanker (1.
show all

Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

Create successful ePaper yourself

Delete template?

Save as template?